"Tumor-free survival" Does Not Outweigh the Adverse Effects of Anti-EGFR Therapy and Chemotherapy in Patients With NSCLC

被引：0
|
作者：
Zheng, Mei-Mei [1 ,2 ]
Wu, Yi-Long [1 ]
机构：
[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, 06 Zhongshan Er Rd, Guangzhou 510080, Peoples R China
[2] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Cardiovasc Inst, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 08期
基金：
中国国家自然科学基金; 中国博士后科学基金;
关键词：
CELL LUNG-CANCER; 1ST-LINE TREATMENT; GEFITINIB;
D O I：
10.1016/j.jtho.2024.04.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1146 / 1150
页数：5
相关论文
共 50 条
  • [21] Adding Concurrent Chemotherapy Significantly Improves the Survival of Stage II-IVb Nasopharyngeal Carcinoma Patients Treated With Concurrent Anti-EGFR Agents
    Yu, Zi-Kun
    Chen, Xu-Yin
    Liu, Si-Han
    Liu, You-Ping
    You, Rui
    Huang, Pei-Yu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Comparison of survival for left-sided KRASwt mCRC patients treated with anti-EGFR based therapy as compared to rightsided mCRC.
    Petruzelka, Lubos B.
    Obermannova, Radka
    Hejduk, Karel
    Ostrizkova, Lenka
    Zdrazilova-Dubska, Lenka
    Brancikova, Dagmar
    Bencsikova, Beatrix
    Vyzula, Rostislav
    Vocka, Michal
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [23] Association of Hypokalemia Incidence and Better Treatment Response in NSCLC Patients: A Meta-Analysis and Systematic Review on Anti-EGFR Targeted Therapy Clinical Trials
    Zhou, Jiawei
    Bai, Jianling
    Yue, Yuanping
    Chen, Xin
    Lange, Theis
    You, Dongfang
    Zhao, Yang
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [24] Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival
    Wieder, Hinrich A.
    Rosenberg, Robert
    Lordick, Florian
    Geinitz, Hans
    Beer, Ambros
    Becker, Karen
    Woertler, Klaus
    Dobritz, Martin
    Siewert, Joerg R.
    Rummeny, Ernst J.
    Stollfuss, Jens C.
    RADIOLOGY, 2007, 243 (03) : 744 - 751
  • [25] Immune checkpoint inhibitor plus anti-EGFR target therapy plus chemotherapy in patients with locally advanced penile squamous cell carcinoma.
    Han, Hui
    An, Xin
    Yan, Ru
    Guo, Shengjie
    Xue, Cong
    Liu, Tingyu
    Tian, Li
    Ma, Huali
    Li, Yonghong
    Qin, Zike
    Liu, Zhuowei
    Zhou, Fang-Jian
    Shi, Yanxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Quantitative analysis of the impact of deepness of response on survival time following patients with metastatic colorectal cancer treated by chemotherapy and anti-EGFR monoclonal antibodies.
    Osumi, Hiroki
    Matsusaka, Satoshi
    Suenaga, Mitsukuni
    Wakatsuki, Takeru
    Ogura, Mariko
    Ozaka, Masato
    Shinozaki, Eiji
    Chin, Keisho
    Mizunuma, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [27] Melatonin and chemotherapy: does the proposed fertoprotective agent impair the anti-tumor effects of cancer therapy?
    Alley, A.
    Bold, C.
    Letourneau, J.
    Constance, J.
    HUMAN REPRODUCTION, 2024, 39 : I369 - I369
  • [28] Bevacizumab and its impact on survival for patients receiving subsequent anti-EGFR therapy: Updated results from the SA metastatic CRC registry.
    Price, Timothy Jay
    Karapetis, Christos Stelios
    Padbury, Robert
    Burge, Matthew E.
    Roy, Amitesh Chandra
    Maddern, Guy
    Roder, David
    Piantadosi, Cynthia
    Townsend, Amanda Rose
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] ANTI-TUMOR NECROSIS FACTOR-A THERAPY AND `PARADOXICAL' ADVERSE EFFECTS IN RHEUMATIC PATIENTS
    Ileana, Filipescu
    Linda, Ghib
    Cristina, Pamfil
    Laura, Damian
    Simona, Senila
    Simona, Rednic
    RHEUMATOLOGY, 2012, 51 : I27 - I27
  • [30] Triplet-drug chemotherapy combined with anti-EGFR antibody as an effective therapy for patients with initially unresectable metastatic colorectal cancer: a meta-analysis
    Tian, Muyou
    Li, Huifen
    Dong, Wenjing
    Li, Yuhong
    Jiang, Ting
    Lv, Yanhua
    Zeng, Jianxiong
    Jiang, Xiaomei
    Yin, Zhaofeng
    Xiao, Jianjun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
12345